Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Outbreak or pseudo-outbreak? Integrating SARS-CoV-2 sequencing to validate infection control practices in an end stage renal disease facility

Bridget L. Pfaff, Craig S. Richmond, Arick P. Sabin, Deena M. Athas, Jessica C. Adams, Megan E. Meller, Kumari Usha, Sarah A. Schmitz, Brian J. Simmons, Andrew J. Borgert, View ORCID ProfileParaic A. Kenny
doi: https://doi.org/10.1101/2020.12.30.20249062
Bridget L. Pfaff
1Departments of Infection Control, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: blpfaff@gundersenhealth.org pakenny@gundersenhealth.org
Craig S. Richmond
2Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arick P. Sabin
3Departments of Infectious Disease Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deena M. Athas
1Departments of Infection Control, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica C. Adams
4Departments of Renal Dialysis, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan E. Meller
1Departments of Infection Control, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kumari Usha
5Departments of Nephrology, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah A. Schmitz
6Departments of Employee Health, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Simmons
1Departments of Infection Control, Gundersen Health System, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Borgert
7Medical Research Department, Gundersen Medical Foundation, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paraic A. Kenny
2Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI 54601
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paraic A. Kenny
  • For correspondence: blpfaff@gundersenhealth.org pakenny@gundersenhealth.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The COVID-19 pandemic of 2020 poses a particularly high risk for End Stage Renal Disease (ESRD) patients and led to a need for facility-wide control plans to prevent introduction and spread of infection within ESRD facilities. Rapid identification of clusters of contemporaneous cases is essential, as these may be indicative of within-facility spread. Nevertheless, in a setting of high community COVID-19 prevalence, a series of ESRD patients may test positive at around the same time without their shared ESRD facility being the nexus for disease spread. Here we describe a series of five cases occurring within an eleven-day period in November 2020 in a hospital-based 32-station ESRD facility in southwest Wisconsin, the subsequent facility-wide testing, and the use of genetic sequence analysis of positive specimens to evaluate whether these cases were linked.

Methods Four patient cases and one staff case were identified in symptomatic individuals by RT-PCR. Facility-wide screening was initiated at the request of local public health and conducted using Abbot BinaxNOW antigen tests. SARS-CoV-2 genome sequences were obtained from residual diagnostic test specimens using an amplicon-based approach on an Ion Torrent S5 sequencer.

Results Residual specimens from 4 of 5 cases were available for sequence analysis. Each sequence was very clearly genetically distinct from the others, indicating that these contemporaneous cases were not linked. Facility-wide screening of 47 staff and 107 patients did not identify any additional cases.

Conclusions These data indicate that despite the outward appearance of a case cluster, the facility did not experience within-facility spread nor serve as the epicenter of a new outbreak, suggesting that the enacted rigorous infection control procedures (screening, masking, distancing) practiced stringently by patients and staff were sufficient to permit dialysis to proceed safely in a very high-risk population under pressure from increasing community spread. These data also demonstrate the utility of rapid turnaround SARS-CoV-2 sequencing in outbreak investigations in settings like ESRD facilities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Gundersen Medical Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Specimens were analyzed in this study under a protocol approved by the Gundersen Health System Institutional Review Board (#2-20-03-008; PI: Kenny) to perform next-generation sequencing on remnant specimens after completion of diagnostic testing.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Sequence data are deposited in GISAID.

https://www.gisaid.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 06, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Outbreak or pseudo-outbreak? Integrating SARS-CoV-2 sequencing to validate infection control practices in an end stage renal disease facility
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Outbreak or pseudo-outbreak? Integrating SARS-CoV-2 sequencing to validate infection control practices in an end stage renal disease facility
Bridget L. Pfaff, Craig S. Richmond, Arick P. Sabin, Deena M. Athas, Jessica C. Adams, Megan E. Meller, Kumari Usha, Sarah A. Schmitz, Brian J. Simmons, Andrew J. Borgert, Paraic A. Kenny
medRxiv 2020.12.30.20249062; doi: https://doi.org/10.1101/2020.12.30.20249062
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Outbreak or pseudo-outbreak? Integrating SARS-CoV-2 sequencing to validate infection control practices in an end stage renal disease facility
Bridget L. Pfaff, Craig S. Richmond, Arick P. Sabin, Deena M. Athas, Jessica C. Adams, Megan E. Meller, Kumari Usha, Sarah A. Schmitz, Brian J. Simmons, Andrew J. Borgert, Paraic A. Kenny
medRxiv 2020.12.30.20249062; doi: https://doi.org/10.1101/2020.12.30.20249062

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5274)
  • Forensic Medicine (3)
  • Gastroenterology (197)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5901)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2026)
  • Radiology and Imaging (350)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)